Sundaram Preethi sold CPRX
December 29, 2025 · Form 4 insider transaction
Sundaram Preethi sold 2,369 shares of Catalyst Pharmaceuticals Inc, a transaction worth N/A. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,369
Price
N/A
Total value
N/A
InsiderSundaram Preethi
Role—
SecurityCommon Stock, par value $0.001 per share
Transaction codeF: Shares withheld for taxes
Transaction dateDecember 29, 2025
Filing dateDecember 30, 2025
Shares owned after54,804
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted common stock.